MA10-MA50 Bull Crossover: Aratana Therapeutics Inc.(PETX)

NASDAQ: PETX (Aratana Therapeutics Inc)

Aratana Therapeutics Inc announced positive results from its pivotal field effectiveness study of capromorelin (AT-002), the company’s innovative therapeutic for appetite stimulation in dogs.

PETX  has closed at $14.85, its traded Volume was 2064.51K shares, PETX opened the Day at $15.15, it made an intraday Low of $14.22, and an intraday High of $16. PETX (Aratana Therapeutics Inc) 52-week High is $20.63, 52-week Low is: $9.2, it has supports at $13.59 and $11.68, resistances at $16.7 and $19.5. PETX’s earning is $-1.22 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -12. Overall, this stock is rated STRONG BUY today.